Boehringer Ingelheim del Ecuador Cia. Ltda.

At Boehringer Ingelheim, the development of medicines for people and animals is at the heart of our work. Our mission is to develop innovative therapies that change lives. Since its founding in 1885, Boehringer Ingelheim has been an independent family company. We are free to pursue our long-term vision, anticipating the health challenges of the future and targeting those areas of need where we can deliver the greatest benefits.
We are a leading global research-driven pharmaceutical company with more than 51,000 employees who add value every day through innovation in three business areas: Human Health, Animal Health and Biopharmaceuticals.
Our high level of investment in R&D drives innovation, enabling the development of next-generation drugs that save lives and improve their quality.
We achieve more scientific opportunities by adhering to the power of partnerships and diversity with community experts from all of the life sciences. Working together, we accelerate the creation of the medical innovation of the future that will transform the lives of patients today, and for generations to come.